| scholarly article | Q13442814 |
| P2093 | author name string | Takeshi Shimizu | |
| Kentaro Tsukamoto | |||
| Takao Tsuji | |||
| Hideyuki Arimitsu | |||
| Keiko Sasaki | |||
| Toshiyasu Shimizu | |||
| P2860 | cites work | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 |
| Infection by Shiga toxin-producing Escherichia coli: an overview | Q33358878 | ||
| Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections | Q33429817 | ||
| Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia | Q34033376 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1. | Q35012362 | ||
| Lincomycin, clindamycin and their applications | Q35648606 | ||
| Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits | Q36165342 | ||
| Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2 | Q36472567 | ||
| Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins | Q38300698 | ||
| Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies | Q38303627 | ||
| Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. | Q38334562 | ||
| Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide | Q38350915 | ||
| Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). | Q40782927 | ||
| Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease | Q43654014 | ||
| Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli | Q45357221 | ||
| Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin | Q46841076 | ||
| Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. | Q54478105 | ||
| Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. | Q54651945 | ||
| Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. | Q54763750 | ||
| Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆ | Q57563815 | ||
| Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933 | Q57563895 | ||
| P433 | issue | 1 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 38-45 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production. | |
| P478 | volume | 57 |
Search more.